Key Insights

Highlights

Treatment Research

2 treatments under study, led by Adalimumab

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown3

Clinical Trials (3)

Showing 3 of 3 trials
NCT05590416UnknownPrimary

A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

NCT05627739UnknownPrimary

A Study of Mycophenolate Mofetil Combined With Glucocorticoid Therapy in Relapse Vogt-Koyanagi-Harada Disease

NCT04126850Unknown

Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infectious Uveitis Disease

Showing all 3 trials

Research Network

Common Treatments

  • Adalimumab1
  • Mycophenolate Mofetil1

Active Sponsors

  • Tianjin Medical University2
  • Fakultas Kedokteran Universitas Indonesia1

Top Investigators

Related Conditions

  • Intermediate Uveitis1
  • Posterior Uveitis1
  • Adalimumab1
  • Anterior Uveitis Idiopathic1
  • Autoimmune Uveitis1

Activity Timeline